Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Therapeutics and Clinical Risk Management|July 3, 2010
Management of ANCA-associated vasculitis: Current trends and future prospectsSally Hamour, Alan D Salama, Charles D PuseyInflammation & Allergy Drug Targets|March 12, 2009
Renal & ocular targets for therapy in Wegener's granulomatosisLavnish Joshi, Sally Hamour, Alan D Salama, et al.American Journal of Nephrology|March 23, 2016
Prolonged Duration of Renal Recovery Following ANCA-Associated GlomerulonephritisAmin Oomatia, Sarah M Moran, Claire Kennedy, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2010
Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitisEstela Nogueira, Sally Hamour, Devika Sawant, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2011
Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitisNicholas Mansfield, Sally Hamour, Anne-Marie Habib, et al.Kidney International Reports|January 11, 2020
Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)-Associated VasculitisAlan D SalamaRheumatology (Oxford, England)|April 30, 2020
IgA vasculitis and anti-GBM disease: two ends of a spectrum of immune complex vasculitisAlan D SalamaBest Practice & Research. Clinical Rheumatology|December 12, 2018
Genetics and pathogenesis of small-vessel vasculitisAlan D SalamaRheumatology Advances in Practice|April 7, 2023
Cocaine-induced granulomatosis with polyangiitis-an under-recognized conditionCharn Gill, Joseph Sturman, Leyla Ozbek, et al.Acute Medicine|March 27, 2025
Taking medicines as prescribed (Picture Quiz)Abdulrahman Al-Mohammad, Dafydd Davies, Sally HamourPageof 14